Fri, May 24, 2013, 2:30 PM EDT - U.S. Markets close in 1 hr 30 mins
We have completed the required pre-clinical studies of NV-143 necessary to complete an Investigational New Drug (IND) application, which we plan to submit to the U.S. Food and Drug Administration (FDA) in July.
company has a huge pipelien do your dd
PRE-CLINICAL ONLY!!!Hmmmmmmmmmm long way to go!!!!BETTER LOCK IN PROFITS!!!